Lonza develops and manufactures medicines for pharma and biotech companies and has sold into India since it became a full sales organisation here in 2007. In 2026 it chose Hyderabad for a global capability centre that handles operational, digital and scientific work.
Ownership and structure
Lonza operates in India through Lonza India Private Limited, a wholly owned subsidiary registered in Gurugram.
What India does for Lonza
Lonza is moving centralised finance, HR, IT, purchasing, quality control, supply chain and marketing work to its Hyderabad centre, which joins its centres in Manchester and Costa Rica.
Investment and deals
In 2011 Lonza said it was investing ₹405 crore in India and launched a research centre at Genome Valley in Hyderabad. The March 2026 announcement of the Hyderabad capability centre did not include an investment figure. About 40 roles from Switzerland are moving to Hyderabad by the end of 2026.
Lonza’s India business
Lonza began in India in 1997 as a liaison office sourcing advanced intermediates. Its Indian subsidiary is registered in Gurugram.
Key moves in India
- 1997: Lonza opened a liaison office in India.
- 2007: It became a full sales and commercial organisation in India.
- 2009: Lonza acquired preclinical biology assets of Simbiosys Biowares in Bengaluru.
- 2011: It launched a research centre at Genome Valley, Hyderabad.
- 2026: Lonza selected Hyderabad in March for a global capability centre.
Where it operates
Lonza runs its India business from Gurugram. It also has a presence in Hyderabad.
At a glance
- Home country: Switzerland
- Global headquarters: Basel
- Sector: Manufacturing & Supply Chains
- Business: Contract drug manufacturing
- Role of India: Sales market, Capability centre
- India entity: Lonza India Private Limited
- Listed in India: No
- India head office: Gurugram
- India offices: Gurugram, Hyderabad
- India headcount: Not available
- In India since: 1997
© 2026 The Narrative Republic
See every foreign company we track in our Foreign Companies in India directory.
